Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,093 | 195 | 99.7% |
| Education | $16.90 | 2 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $874.99 | 54 | $0 (2024) |
| Janssen Biotech, Inc. | $819.59 | 33 | $0 (2024) |
| GENZYME CORPORATION | $664.24 | 19 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $649.16 | 26 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $552.95 | 18 | $0 (2024) |
| Kerecis Limited | $430.64 | 5 | $0 (2024) |
| Incyte Corporation | $219.96 | 8 | $0 (2024) |
| LEO Pharma Inc. | $151.02 | 7 | $0 (2024) |
| UCB, Inc. | $117.30 | 5 | $0 (2024) |
| Arcutis Biotherapeutics, Inc. | $103.10 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,725 | 65 | Janssen Biotech, Inc. ($394.98) |
| 2023 | $1,626 | 57 | Regeneron Healthcare Solutions, Inc. ($291.05) |
| 2022 | $1,230 | 55 | ABBVIE INC. ($368.22) |
| 2021 | $529.05 | 20 | GENZYME CORPORATION ($145.43) |
All Payment Transactions
197 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $29.19 | General |
| Category: Immunology | ||||||
| 12/05/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $19.25 | General |
| Category: IMMUNOLOGY | ||||||
| 11/20/2024 | PFIZER INC. | CIBINQO (Drug), LITFULO | Food and Beverage | In-kind items and services | $28.92 | General |
| Category: Inflammation & Immunology | ||||||
| 11/14/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $20.22 | General |
| Category: IMMUNOLOGY | ||||||
| 11/13/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $25.40 | General |
| Category: Inflammation | ||||||
| 11/12/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $5.68 | General |
| Category: IMMUNOLOGY | ||||||
| 11/11/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $18.49 | General |
| Category: Dermatology | ||||||
| 11/07/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $14.97 | General |
| Category: Immunology | ||||||
| 11/05/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $11.10 | General |
| Category: IMMUNOLOGY | ||||||
| 10/30/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $19.51 | General |
| Category: Immunology | ||||||
| 10/29/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $111.40 | General |
| Category: Immunology | ||||||
| 10/23/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $31.22 | General |
| 10/17/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $26.01 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/17/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $21.42 | General |
| Category: Immunology | ||||||
| 10/17/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $0.60 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/15/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $18.75 | General |
| Category: IMMUNOLOGY | ||||||
| 10/10/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $56.21 | General |
| Category: Immunology | ||||||
| 10/09/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $85.32 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/07/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $9.73 | General |
| Category: IMMUNOLOGY | ||||||
| 09/26/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $24.93 | General |
| Category: DERMATOLOGY | ||||||
| 09/25/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $21.50 | General |
| Category: Inflammation | ||||||
| 09/25/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $14.03 | General |
| Category: Immunology | ||||||
| 09/16/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $19.88 | General |
| 09/12/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $44.91 | General |
| Category: Immunology | ||||||
| 09/11/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $30.04 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 36 | 2,930 | 5,347 | $1.4M | $272,505 |
| 2022 | 28 | 2,163 | 4,194 | $843,033 | $191,674 |
| 2021 | 22 | 1,104 | 1,877 | $401,604 | $97,687 |
All Medicare Procedures & Services
86 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 412 | 723 | $174,243 | $41,733 | 24.0% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 168 | 271 | $128,725 | $29,089 | 22.6% |
| 17111 | Destruction of skin growth, 15 or more growths | Office | 2023 | 226 | 330 | $123,750 | $28,794 | 23.3% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 250 | 349 | $113,425 | $23,547 | 20.8% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 252 | 365 | $105,850 | $16,164 | 15.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 140 | 184 | $62,704 | $14,528 | 23.2% |
| J7308 | Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | Office | 2023 | 41 | 47 | $46,295 | $14,392 | 31.1% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 144 | 381 | $55,245 | $13,621 | 24.7% |
| 11301 | Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm | Office | 2023 | 86 | 143 | $50,050 | $8,549 | 17.1% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 212 | 296 | $56,240 | $7,327 | 13.0% |
| 96574 | Application of light with debridement to destroy precancer skin growth | Office | 2023 | 41 | 44 | $35,860 | $7,321 | 20.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 178 | 229 | $34,579 | $6,793 | 19.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 69 | 69 | $30,321 | $6,558 | 21.6% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Facility | 2023 | 56 | 65 | $55,575 | $6,315 | 11.4% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 172 | 1,298 | $25,960 | $6,015 | 23.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 70 | 70 | $21,070 | $4,396 | 20.9% |
| 11606 | Removal of cancer skin growth of body, arms, or legs, more than 4.0 cm | Facility | 2023 | 19 | 19 | $23,275 | $3,576 | 15.4% |
| 13132 | Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm | Facility | 2023 | 19 | 19 | $24,985 | $3,519 | 14.1% |
| 77427 | Radiation treatment management, 5 treatment sessions | Office | 2023 | 21 | 26 | $12,806 | $3,414 | 26.7% |
| 11311 | Shaving of skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm | Office | 2023 | 32 | 36 | $14,040 | $2,856 | 20.3% |
| 11302 | Shaving of skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 25 | 37 | $14,430 | $2,843 | 19.7% |
| 11604 | Removal of cancer skin growth of body, arms, or legs, 3.1-4.0 cm | Facility | 2023 | 21 | 24 | $20,760 | $2,594 | 12.5% |
| 13121 | Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm | Facility | 2023 | 16 | 17 | $20,230 | $2,457 | 12.1% |
| 12052 | Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.6-5.0 cm | Facility | 2023 | 15 | 17 | $15,045 | $2,100 | 14.0% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 24 | 25 | $9,000 | $2,099 | 23.3% |
About Tanner Cavanaugh
Tanner Cavanaugh is a Emergency Medical Technician, Basic healthcare provider based in Modesto, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/04/2014. The National Provider Identifier (NPI) number assigned to this provider is 1811394976.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Tanner Cavanaugh has received a total of $5,110 in payments from pharmaceutical and medical device companies, with $1,725 received in 2024. These payments were reported across 197 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($5,093).
As a Medicare-enrolled provider, Cavanaugh has provided services to 6,197 Medicare beneficiaries, totaling 11,418 services with total Medicare billing of $561,866. Data is available for 3 years (2021–2023), covering 86 distinct procedure/service records.
Practice Information
- Specialty Emergency Medical Technician, Basic
- Other Specialties Basic|Medical
- Location Modesto, CA
- Active Since 12/04/2014
- Last Updated 05/17/2021
- Taxonomy Code 146N00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1811394976
Products in Payments
- DUPIXENT (Biological) $1,180
- SKYRIZI (Biological) $811.35
- TREMFYA (Drug) $722.75
- Kerecis Omega3 SurgiClose (Device) $388.33
- COSENTYX (Drug) $326.31
- COSENTYX (Biological) $245.85
- OPZELURA (Drug) $219.96
- REMICADE (Biological) $165.46
- ADBRY (Biological) $124.35
- Otezla (Drug) $101.62
- Sotyktu (Drug) $83.18
- TALTZ (Drug) $76.88
- Bimzelx (Biological) $47.37
- Cimzia (Drug) $45.41
- VTAMA (Drug) $43.43
- Kerecis Omega3 Wound (Device) $42.31
- LIBTAYO (Biological) $36.92
- XOLAIR (Drug) $32.95
- CIBINQO (Drug) $28.92
- RINVOQ (Biological) $28.88
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.